Xu Chenyang, Li Xinrui, Wang Hui, Yue Zihan, Shen Linyuan, He Jianan, Liu Zheng, Zhao Weiying
School of Medicine Shaoxing University Shaoxing China.
Bates College Lewiston Maine USA.
JGH Open. 2025 May 12;9(5):e70165. doi: 10.1002/jgh3.70165. eCollection 2025 May.
The global incidence of liver diseases is on the rise, and targeting gut microbiota has become a new strategy for treating liver diseases. This study provides a comprehensive and objective analysis of the potential protective role of gut microbiota in liver disease, highlighting the need for continued research in this area.
After literature screening, 24 related articles were included in the study. After article quality and risk of bias assessment, data extraction and data collation were carried out, and then comprehensive analysis was carried out using stata12.0 software.
From the perspective of microbial community, most of the microbial communities at the phylum level are risk factors; from the perspective of the top ten families, the intestinal microbial communities play an obvious harmful role in Primary Biliary Cholangitis.From the perspective of disease, the microbial communities at the genus level mostly have protective effects on Chronic Hepatitis B ,Fatty Liver;and Primary Liver Cancer.
Gut microbiota plays a significant role in the occurrence of liver diseases, and different bacterial levels play different roles in the disease.
全球肝脏疾病的发病率呈上升趋势,针对肠道微生物群已成为治疗肝脏疾病的新策略。本研究对肠道微生物群在肝脏疾病中的潜在保护作用进行了全面客观的分析,强调了该领域持续研究的必要性。
经文献筛选,本研究纳入24篇相关文章。在进行文章质量和偏倚风险评估后,进行数据提取和数据整理,然后使用stata12.0软件进行综合分析。
从微生物群落角度来看,门水平的大多数微生物群落是危险因素;从前十大菌属角度来看,肠道微生物群在原发性胆汁性胆管炎中起明显有害作用。从疾病角度来看,属水平的微生物群大多对慢性乙型肝炎、脂肪肝和原发性肝癌具有保护作用。
肠道微生物群在肝脏疾病的发生中起重要作用,不同细菌水平在疾病中发挥不同作用。